Poma Eric E 4
4 · Calidi Biotherapeutics, Inc. · Filed Apr 25, 2025
Insider Transaction Report
Form 4
Poma Eric E
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-22+726,412→ 726,412 totalExercise: $0.47Exp: 2035-04-22→ Common Stock (726,412 underlying)
Footnotes (2)
- [F1]On April 22, 2025 (the "Grant Date"), the compensation committee and board of directors of Calidi Biotherapeutics, Inc. ("Issuer") approved an inducement grant to the Reporting Person of 726,412 stock options (the "Options"), pursuant to the exception under Section 711 NYSE American, at a per share exercise price of $0.4690, which is equal to the closing price of the Issuer's common stock on the Grant Date.
- [F2]25% of the options will vest upon the one (1) year anniversary of 04/22/2025, and the remaining 75% of the options will vest in 1/36th installments on the last day of each monthly period subject to the Reporting Person's continued service to the Issuer.